M T Nurmohamed Selected Research

M T Nurmohamed Research Topics

Disease

39	Rheumatoid Arthritis 03/2022 - 12/2000
17	Ankylosing Spondylitis 11/2022 - 12/2005
13	Inflammation (Inflammations) 11/2021 - 11/2006
12	Necrosis 11/2022 - 03/2007
6	Rheumatic Diseases (Rheumatism) 03/2022 - 04/2009
3	Psoriatic Arthritis 03/2022 - 04/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2013 - 05/2006
2	Insulin Resistance 02/2021 - 03/2007
2	Arthritis (Polyarthritis) 01/2015 - 09/2008
2	Fatigue 03/2010 - 01/2009
2	Diabetes Mellitus 07/2008 - 03/2007
2	Venous Thromboembolism 08/2007 - 10/2001
1	Disease Progression 05/2022
1	Non-Radiographic Axial Spondyloarthritis 05/2022
1	Back Pain (Backache) 05/2022
1	Hypothyroidism 11/2021
1	Joint Diseases (Joint Disease) 02/2021
1	Synovitis 01/2020
1	Gout 01/2020
1	Left Ventricular Dysfunction 01/2018
1	Heart Failure 01/2015
1	Liver Diseases (Liver Disease) 12/2012
1	Arthralgia (Joint Pain) 09/2008
1	Hypertension (High Blood Pressure) 02/2008
1	Ulcer 02/2008
1	Nociceptive Pain 06/2007
1	Obesity 03/2007
1	Aplastic Anemia (Anemia, Hypoplastic) 12/2000
1	Hemorrhage 06/2000

Drug/Important Bio-Agent (IBA)

13	Etanercept (Enbrel)FDA Link 05/2022 - 11/2006
11	Adalimumab (Humira)FDA Link 07/2019 - 03/2007
9	AntibodiesIBA 11/2021 - 05/2006
8	LipidsIBA 01/2016 - 11/2006
5	C-Reactive ProteinIBA 03/2018 - 05/2005
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 03/2007
5	HDL CholesterolIBA 09/2010 - 09/2003
5	Infliximab (Remicade)FDA Link 05/2010 - 04/2005
4	Pharmaceutical PreparationsIBA 11/2022 - 02/2015
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2009 - 09/2003
3	Biological ProductsIBA 05/2022 - 02/2015
3	Anti-Citrullinated Protein AntibodiesIBA 11/2021 - 09/2008
3	CholesterolIBA 09/2010 - 11/2006
2	Immunoglobulin G (IgG)IBA 11/2021 - 04/2009
2	Tumor Necrosis Factor InhibitorsIBA 07/2019 - 01/2009
2	GlucocorticoidsIBA 09/2012 - 09/2003
2	HDL LipoproteinsIBA 09/2010 - 05/2009
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2009 - 02/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2008 - 05/2006
2	Triglycerides (Triacylglycerol)IBA 02/2007 - 11/2006
2	Leflunomide (Arava)FDA LinkGeneric 11/2006 - 12/2005
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 11/2021
1	acetyl 4-aminosalicylic acidIBA 11/2021
1	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2021
1	lipid-associated sialic acid (LASA)IBA 07/2021
1	Prednisolone (Predate)FDA LinkGeneric 07/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	1- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA 01/2020
1	Uric Acid (Urate)IBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2019
1	golimumab FDA Link 01/2018
1	tocilizumab (atlizumab)FDA Link 03/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2017
1	Iodide Peroxidase (Deiodinase)IBA 12/2013
1	EnzymesIBA 12/2012
1	AdipokinesIBA 09/2012
1	ResistinIBA 09/2012
1	Rituximab (Mabthera)FDA Link 08/2009
1	Interleukin-10 (Interleukin 10)IBA 08/2009
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 07/2009
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 05/2009
1	EpitopesIBA 09/2008
1	cyclic citrullinated peptideIBA 09/2008
1	Methotrexate (Mexate)FDA LinkGeneric 07/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2007
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2007
1	FructosamineIBA 03/2007
1	CytokinesIBA 03/2007
1	Lipoprotein(a)IBA 02/2007
1	ApolipoproteinsIBA 02/2007
1	Apolipoproteins B (ApoB)IBA 02/2007
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2006
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 12/2000
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2000
1	AnticoagulantsIBA 06/2000

Therapy/Procedure

11	Therapeutics 11/2021 - 06/2000
1	Lasers (Laser) 05/2009
1	Surgical Casts (Plaster Cast) 08/2007
1	Arthroplasty 10/2001